The 'Spanish' influenza pandemic of 1918-19 was the most devastating outbreak of infectious disease in recorded history. At least 20 million people died from their illness, which was characterized by an unusually severe and rapid clinical course. The complete sequencing of several genes of the 1918 influenza virus has made it possible to study the functions of the proteins encoded by these genes in viruses generated by reverse genetics, a technique that permits the generation of infectious viruses entirely from cloned complementary DNA. Thus, to identify properties of the 1918 pandemic influenza A strain that might be related to its extraordinary virulence, viruses were produced containing the viral haemagglutinin (HA) and neuraminidase (NA) genes of the 1918 strain. The HA of this strain supports the pathogenicity of a mouse-adapted virus in this animal. Here we demonstrate that the HA of the 1918 virus confers enhanced pathogenicity in mice to recent human viruses that are otherwise non-pathogenic in this host. Moreover, these highly virulent recombinant viruses expressing the 1918 viral HA could infect the entire lung and induce high levels of macrophage-derived chemokines and cytokines, which resulted in infiltration of inflammatory cells and severe haemorrhage, hallmarks of the illness produced during the original pandemic.
Zaire ebolavirus (ZEBOV) causes severe hemorrhagic fever in humans and nonhuman primates, with fatality rates in humans of up to 90%. The molecular basis for the extreme virulence of ZEBOV remains elusive. While adult mice resist ZEBOV infection, the Mayinga strain of the virus has been adapted to cause lethal infection in these animals. To understand the pathogenesis underlying the extreme virulence of Ebola virus (EBOV), here we identified the mutations responsible for the acquisition of the high virulence of the adapted Mayinga strain in mice, by using reverse genetics. We found that mutations in viral protein 24 and in the nucleoprotein were primarily responsible for the acquisition of high virulence. Moreover, the role of these proteins in virulence correlated with their ability to evade type I interferon-stimulated antiviral responses. These findings suggest a critical role for overcoming the interferon-induced antiviral state in the pathogenicity of EBOV and offer new insights into the pathogenesis of EBOV infection.
Infectious virus-like particle (iVLP) systems have recently been established for several negative-strand RNA viruses, including the highly pathogenic Zaire ebolavirus (ZEBOV), and allow study of the viral life cycle under biosafety level 2 conditions. However, current systems depend on the expression of viral helper nucleocapsid proteins in target cells, thus making it impossible to determine whether ribonucleoprotein complexes transferred by iVLPs are able to facilitate initial transcription, an indispensable step in natural infection. Here we describe a ZEBOV iVLP system which overcomes this limitation and show that VP24 is essential for the formation of a functional ribonucleoprotein complex.Ebola virus (EBOV) causes severe hemorrhagic fever in humans, for which treatment is currently unavailable (6, 8). To study particle morphogenesis, genome packaging, and virion entry into target cells under biosafety level 2 conditions, an infectious virus-like particle (iVLP) system for Zaire ebolavirus (ZEBOV) was established (20). This system extends the original minigenome systems (4, 7, 14) by including VP24, VP40, and GP to produce iVLPs which resemble wild-type (WT) virions but contain minigenomes instead of full-length viral genomes. These iVLPs can deliver the minigenomes to target cells, where they are transcribed and replicated in the presence of helper ribonucleoprotein (RNP) components (the nucleoprotein [NP], VP35, VP30, and L components). Similar systems are available for other negative-sense RNA viruses, but RNP components must always be provided to target cells in trans, via either helper virus infection or expression plasmid transfection (12,(15)(16)(17)(19)(20)(21). Therefore, it is impossible to determine whether iVLPs contain fully functional RNP complexes or whether they contain minigenomes but are unable to facilitate initial transcription, as is necessary in virus infection. EBOV VP24 has been described as a minor matrix protein, but its contribution to budding is controversial (10, 13). Electron microscopic studies imply a role in the formation of nucleocapsid-like structures (11), while another study suggests that VP24 is unnecessary for the packaging and delivery of minigenomes by iVLPs (20). To better understand the contribution of VP24 to morphogenesis, we established an iVLP system with naïve target cells to allow assessment of iVLP-associated RNP complex function. As a first step, an iVLP system based on that previously described (20) was established in our laboratory (Fig. 1A). 293T cells (p0) were transfected using FuGENE (Roche) with plasmids encoding each ZEBOV structural protein (125 ng pCAGGS-NP, 125 ng pCAGGS-VP35, 75 ng pCAGGS-VP30, 1,000 ng pCAGGS-L, 250 ng pCAGGS-GP, 250 ng pCAGGS-VP40, and 60 ng pCAGGS-VP24) and a T7-driven minigenome encoding a Renilla luciferase reporter (250 ng), which is detectable in minute amounts (23). Cell supernatant containing released iVLPs was harvested 3 days posttransfection, cleared of cellular debris, and used to infect target 293T cells (p1) previ...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.